Copertina

Targeting enabled homolog with daunorubicin inhibits ERK1/2/c‐Fos pathway and suppresses hepatocellular carcinoma progression

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Zhi‐Mei Li, Guan Liu, Qing‐Qing Liu, Wei‐Ming You, Ming‐Gao Zhao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical and Translational Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Targeted demethylation of the BRD7 promoter based on CRISPR/dCas9 system inhibits the malignant progression of nasopharyngeal carcinoma
di: Jianxia Wei, et al.
Pubblicazione: (2026)

Targeting receptor for activated C kinase 1 with a small molecule induces mitotic catastrophe and suppresses lipid metabolic reprogramming in hepatocellular carcinoma
di: Longyan Wang, et al.
Pubblicazione: (2025)

Targeting c‐Myc transactivation by LMNA inhibits tRNA processing essential for malate‐aspartate shuttle and tumour progression
di: Jianqun Wang, et al.
Pubblicazione: (2024)

PCDHGB7 inhibits the progression of triple‐negative breast cancer by suppressing XRCC5/MYC‐mediated ribosome biogenesis
di: Ming Shan, et al.
Pubblicazione: (2025)

Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma
di: Shuai Yang, et al.
Pubblicazione: (2024)

Beyond tumour suppression: cGAS‐STING pathway in urologic malignancies: Context‐dependent duality and therapeutic implications
di: Qi Wei, et al.
Pubblicazione: (2025)

BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively
di: Cong‐Rong Li, et al.
Pubblicazione: (2024)

Targeting c‐Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple‐negative breast cancer
di: Xiaojie Liang, et al.
Pubblicazione: (2025)

SHP2 inhibition and adjuvant therapy synergistically target KIT‐mutant GISTs via ERK1/2‐regulated GSK3β/cyclin D1 pathway
di: Chunxiao He, et al.
Pubblicazione: (2025)

METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination
di: Zhuonan Liu, et al.
Pubblicazione: (2025)

Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway
di: Ying Zhu, et al.
Pubblicazione: (2026)

Sodium pump subunit NKAα1 protects against diabetic endothelial dysfunction by inhibiting ferroptosis through the autophagy‐lysosome degradation of ACSL4
di: Xue‐Xue Zhu, et al.
Pubblicazione: (2025)

High‐fidelity CRISPR/Cas12a dual‐crRNA screening reveals novel synergistic interactions in hepatocellular carcinoma
di: Qian Chen, et al.
Pubblicazione: (2024)

Targeting Zfp36 to combat cardiac hypertrophy: Insights into ferroptosis pathways
di: Mingyu Zhang, et al.
Pubblicazione: (2025)

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity
di: Xiaochen Wang, et al.
Pubblicazione: (2025)

Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application
di: Lin Su, et al.
Pubblicazione: (2024)

Pan‐cancer multi‐omics reveals DCAF7 as an immune‐modulating prognostic driver and Wnt/β‐catenin activator in hepatocellular carcinoma
di: Ruina Luan, et al.
Pubblicazione: (2025)

PUS7‐dependent pseudouridylation of ALKBH3 mRNA inhibits gastric cancer progression
di: Yongxia Chang, et al.
Pubblicazione: (2024)

KMT2D‐mediated H3K4me1 recruits YBX1 to facilitate triple‐negative breast cancer progression through epigenetic activation of c‐Myc
di: Bing Yao, et al.
Pubblicazione: (2024)

Targeting biomolecular condensates to inhibit breast cancer
di: Xiaoxue Zhou, et al.
Pubblicazione: (2025)

RNF39 promotes colorectal cancer progression by driving RINT1 degradation and suppressing ER stress‐induced apoptosis
di: Lu Chen, et al.
Pubblicazione: (2025)

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
di: Bin Zheng, et al.
Pubblicazione: (2024)

SKA3/PTTG1/c‐MYC signal loop drives the progression of colorectal cancer
di: Hao Zhang, et al.
Pubblicazione: (2024)

Targeting the MDK/c‐Myc complex to overcome temozolomide resistance in glioma
di: Xiaonan Xi, et al.
Pubblicazione: (2025)

Fusobacterium nucleatum promotes anastomotic leakage by activating epithelial cells through the NOD1/RIPK2/ERK signalling pathway to drive IL‐1β‐induced neutrophil chemotaxis and collagen degradation
di: Zixian Wei, et al.
Pubblicazione: (2025)

Snai2‐mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB
di: Li‐Juan Jiang, et al.
Pubblicazione: (2024)

Large‐scale cluster randomised trial reveals effectiveness of Helicobacter pylori eradication for gastric cancer prevention
di: Zong‐Chao Liu, et al.
Pubblicazione: (2025)

CDK7 inhibition promotes glioblastoma cell death through convergent transcriptional and metabolic stress pathways
di: Thomas Freitag, et al.
Pubblicazione: (2025)

METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m6A modification of ANKRD22 mRNA
di: Lvyuan Li, et al.
Pubblicazione: (2024)

Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
di: Zheng Wu, et al.
Pubblicazione: (2025)

CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
di: YaoMing Zheng, et al.
Pubblicazione: (2025)

Targeting CLEC4E in immunosuppressive tumour‐associated macrophages via BET inhibition
di: Mengting Liao, et al.
Pubblicazione: (2025)

A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
di: Xingxing Li, et al.
Pubblicazione: (2025)

LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53‐driven tumour progression through miR‐5683/FGF2
di: Nannan Liu, et al.
Pubblicazione: (2024)

Targeting the chromatin remodelling protein Brahma‐related gene 1 for intervention of pulmonary fibrosis
di: Teng Wu, et al.
Pubblicazione: (2024)

Hypoxia‐induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9‐mediated GSK3β/β‐catenin signalling
di: Jia‐cheng Xu, et al.
Pubblicazione: (2025)

Single‐cell and spatial omics unravel the spatiotemporal biology of tumour border invasion and haematogenous metastasis
di: Xifu Cheng, et al.
Pubblicazione: (2024)

Milk fat globule—EGF factor 8/ATP‐binding cassette subfamily E member 1 axis maintains mitophagy flux homeostasis to suppress ferroptosis in acute pancreatitis
di: Yifan Ren, et al.
Pubblicazione: (2026)

PARylation of HMGA1 desensitizes esophageal squamous cell carcinoma to olaparib
di: Xin‐Yuan Lei, et al.
Pubblicazione: (2024)

Immunostimulatory effects of Toll‐like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris
di: Changxing Gao, et al.
Pubblicazione: (2024)